Skip to main content

Table 2 Comparison of patients with complicated appendicitis for 2019 pre-COVID cohort vs. 2020 COVID cohort

From: Impact of the COVID-19 pandemic on incidence and severity of acute appendicitis: a comparison between 2019 and 2020

Characteristic

2019 control cohort (n = 245)

2020 COVID-19 cohort (n = 283)

P value

Age, median (IQR), years

49 (33–65)

50 (32–64)

0.946

ASA > 1, no./total no. (%)

126/225 (56.0)

131/239 (54.8)

0.797

Duration of symptoms > 24 h, no./total no. (%)

164/241 (68.0)

214/281 (76.2)

0.039

Types of complicated appendicitis, no./total no. (%)

 Gangrenous

45/245 (18.4)

50/283 (17.7)

0.835

 Perforation

157/245 (64.1)

179/283 (63.3)

0.843

 Abscess or infiltrate

43/245 (17.6)

54/283 (19.1)

0.651

Conservative treatment, no./total no. (%)

31/245 (12.7)

41/283 (14.5)

0.540

In-hospital delay in operated patients, median (IQR), hours

7.8 (5.0–13.3)

6.7 (4.6–12.1)

0.152

Postoperative complicationa, no./total no. (%)

40/214 (18.7)

45/242 (18.6)

0.979

Severe postoperative complicationa b, no./total no. (%)

11/245 (5.1)

13/281 (5.4)

0.904

  1. Abbreviations: ASA American Society of Anesthesiologists, IQR interquartile range
  2. aPatients for whom surgery was the initial treatment
  3. bSevere complications are defined as Clavien-Dindo IIIa or higher